Update
$Vir Biotechnology (VIR.US)$ Vir Biotechnology Announced New Preliminary Data From Phase 2 SOLSTICE Hepatitis Delta Trial, Showing Tobevibart Alone Or Combined With Elebsiran Was Generally Well Tolerated And Patients Achieved High Virologic Response And ALT Normalization
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
QMengColdJoke : Need this push to make a bottom and back to a fair price say 20. This treatment is good, has similar negative rate comparing to Hepcludrex (GILD) bought ). It confirms this company has a real science. But not miracle…
Trytosaveabit OP QMengColdJoke : Can’t say I disagree at all! GL
QMengColdJoke Trytosaveabit OP : I added a little and will add more if there’s a dip. try to average down to 23 (top of big gap). This pretty babee really gave me huge loss.
Trytosaveabit OP QMengColdJoke : Gotcha! Yeah im afraid there will be a pullback before the next catalyst? Hope I’m wrong and it would just either consolidate after today a bit or start a steady uptrend. I just am not confident of that yet! Like MAIA! Was on a beautiful uptrend for over 10 days! Yesterday good news comes out and it’s now down about 30% or so from yesterday PM! Grrrr
QMengColdJoke Trytosaveabit OP : Yeah, I think there will be a pull back consolidation. consolidation makes uptrend longer (get ride of WSB gamblers)
Trytosaveabit OP QMengColdJoke : Agreed!